About GondolaBio

GondolaBio is a clinical-stage biopharmaceutical company focused on developing next-generation therapeutics for genetic diseases. Originally launched as BridgeBioX, a subsidiary of BridgeBio, GondolaBio secured $300M in private financing from external investors in 2024 and became an independent company within the BridgeBio ecosystem. The company aims to leverage cutting-edge biological research to create breakthrough medicines addressing high unmet needs across multiple therapeutic areas, including neurology, pulmonology, cardiology, nephrology, and endocrinology. Located on the Stanford Life Sciences campus, GondolaBio fosters a unique hybrid environment where top scientists from around the world collaborate with senior leadership and advisors, blending industry expertise with academic innovation.

About BridgeBio

BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company has built a portfolio of 20+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including genetic dermatology, precision oncology, cardiology, endocrinology, neurology, pulmonology, and renal disease, with two approved drugs.

Our focus on scientific excellence and rapid execution aim to translate today’s discoveries into tomorrow’s medicines. We have U.S. offices in San Francisco, Palo Alto, and Raleigh, with small satellites in other parts of the country. We also have international offices in Montreal, Canada, and Zurich, Switzerland, and are expanding across Europe.

To learn more about our story and company culture, visit us at https://bridgebio.com

Who You Are

The asset acquisition team finds and evaluates therapeutic ideas for GondolaBio to pursue. The team works closely with members of GondolaBio’s Investment Committee, which is composed of veteran drug developers and renowned academic scientists. As a key member of the team, this position will help set the culture and business development of the company and will be the face of the organization. In particular, the duties of the Associate/Senior Associate will be to research, evaluate, and advocate for both particular investment opportunities and broader therapeutic areas for GondolaBio to consider.

Responsibilities

• Deeply evaluate all aspects of a therapeutic program—from genetic rationale and pre-clinical evidence all the way to the development plan and clinical trial design 
• Advocate for those that fit our goal of targeting the genetic source of a disease by building a scientific and business case for each potential investment 
• Interface with leading academics, patient advocacy groups, biotechs, and entrepreneurs 
• Lead internal discussions with management and the Investment Committee 
• Establish a focused investment strategy and follow through to identify new investment opportunities 
• Coordinate and work with a talented team of internal subject-matter experts—including clinical, commercial, and disease experts—to dive as deeply as needed for each project 

No matter your role at BridgeBio, successful team members are:

• Patient Champions, who put patients first and uphold strict ethical standards
• Entrepreneurial Operators, who drive toward practical solutions and have an ownership mindset
• Truth Seekers, who are detailed, rational, and humble problem solvers
• Individuals Who Inspire Excellence in themselves and those around them
• High-quality executors, who execute against goals and milestones with quality, precision, and speed

Education, Experience & Skills Requirements

• A strong aptitude for and interest in science 
• Excellent communication skills including the ability to express ideas concisely and cogently in writing and with PowerPoint 
• An advanced technical degree; MD or Ph.D. is preferred 
• Previous experience working at one of the following: 
• Top tier consulting firm in the life sciences 
• Venture capital 
• Business development role in a biotech or life science startup  
• Post-docs with some experience or strong interest in the business of biotech 
• Experience in and confidence with working across a wide range of therapeutic areas 
• Broad knowledge of biotech and pharmaceutical companies in the precision medicine area 
• Curious, has a strong work ethic, and values teamwork 
• A self-starter who loves to learn and will bring great energy to work each day 
• A passion for helping patients 

This is an in person, not remote work position. 

What We Offer

• Patient Days, where we are fortunate to hear directly from individuals living with the conditions we are seeking to impact throughout the year and learn how we can improve our efforts
• A culture inspired by our values: put patients first, think independently, be radically transparent, every minute counts, and let the science speak
• An unyielding commitment to always putting patients first. Learn more about how we do this here
• A de-centralized model that enables our program teams to focus on advancing science and helping patients. Our affiliate structure is designed to eliminate bureaucracy and put decision-making power in the hands of those closest to the science
• A place where you own the vision – both for your program and your own career path
• A collaborative, fast-paced, data-driven environment where we inspire ourselves and each other to always perform at the top of our game
• Access to learning and development resources to help you get in the best professional shape of your life
• Robust and market-competitive compensation & benefits package (Base, Performance Bonus, Equity, health, welfare & retirement programs)
• Flexible PTO
• Rapid career advancement for strong performers
• Potential ability to work on multiple BridgeBio Pharma programs across multiple therapeutic areas over time 
• Partnerships with leading institutions
• Commitment to Diversity, Equity & Inclusion